Proteinuria/pre‐eclampsia · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in proteinuria/pre‐eclampsia compared with no antihypertensive drugs/placebo (low certainty).
1 finding from 1 review
Total reported fetal or neonatal deaths (including miscarriage) · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in total reported fetal or neonatal deaths (including miscarriage) compared with no antihypertensive drugs/placebo (moderate certainty).
1 finding from 1 review
Small‐for‐gestational age · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in small‐for‐gestational age compared with no antihypertensive drugs/placebo (moderate certainty).
1 finding from 1 review
Preterm birth · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in preterm birth (< 37 weeks) compared with no antihypertensive drugs/placebo (moderate certainty).
1 finding from 1 review
Maternal death · women with mild to moderate hypertension during pregnancy
It is very uncertain whether any antihypertensive drug changes maternal death compared with no antihypertensive drugs/placebo (very low certainty).
1 finding from 1 review
All‐cause mortality short‐term · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes all‐cause mortality short‐term compared with moderate NMB (very low certainty).
1 finding from 1 review
Health‐related quality of life · adults undergoing intra‐ and transperitoneal laparoscopic procedures
1 finding from 1 review
Serious adverse events (SAEs) start of surgery until 8 hours after surgery · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes serious adverse events (SAEs) start of surgery until 8 hours after… compared with moderate NMB (very low certainty).
1 finding from 1 review
Short‐term serious adverse events (SAEs) · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes short‐term serious adverse events (SAEs) compared with moderate NMB (very low certainty).
1 finding from 1 review
Satisfaction with the decision‐making process · women aged 40 to 75 years at average to moderate risk of breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Knowledge of all the options · women aged 38 to 71 years at average to moderate risk of breast cancer
Some components of shared decision‐making, including clarification… showed no clear difference in knowledge of all the options compared with control (low certainty).
1 finding from 1 review
Adherence to the chosen option · women aged 38 to 71 years at average to moderate risk of breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Choice of an option aligned with each woman’s values and preferences · women aged 38 to 71 years at average to moderate risk of breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Woman's involvement · women aged 38 to 71 years at average to moderate risk of breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mental health outcomes · women aged 38 to 71 years at average to moderate risk of breast cancer
Some components of shared decision‐making, including clarification… showed no clear difference in mental health outcomes compared with control (low certainty).
1 finding from 1 review
Satisfaction with the decision‐making process · women aged 40 to 75 years at average to moderate risk of breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Confidence in the decision made · women aged 40 to 75 years at average to moderate risk of breast cancer
Studies focused only on enhanced communication, without… showed no clear difference in confidence in the decision made compared with control (low certainty).
1 finding from 1 review
Knowledge of all the options · women aged 40 to 75 years at average to moderate risk of breast cancer
Studies focused only on enhanced communication, without… leads to higher knowledge of all the options*** compared with control (high certainty).
1 finding from 1 review
Adherence to the chosen option · women aged 40 to 75 years at average to moderate risk of breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Choice of an option aligned with each woman’s values and preferences · women aged 40 to 75 years at average to moderate risk of breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found